ARROWHEAD PHARMACEUTICALS, INC. Common Stock, Value, Issued
ARROWHEAD PHARMACEUTICALS, INC. (ARWR) had Common Stock, Value, Issued of $237.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:CommonStockValue · last filed 2026-08-04
- 2026-06-30: Common Stock, Value, Issued $237.00K.
- 2026-03-31: Common Stock, Value, Issued $236.00K.
- 2025-12-31: Common Stock, Value, Issued $233.00K.
- 2025-09-30: Common Stock, Value, Issued $231.00K.
| Period end | Common Stock, Value, Issued | Common Stock, Value, Issued as first filed |
|---|---|---|
| 2026-06-30 | $237.00K 10-Q · filed 2026-08-04 | |
| 2026-03-31 | $236.00K 10-Q · filed 2026-05-07 | |
| 2025-12-31 | $233.00K 10-Q · filed 2026-02-05 | |
| 2025-09-30 | $231.00K 10-Q · filed 2026-08-04 | |
| 2025-06-30 | $230.00K 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $230.00K 10-Q · filed 2025-05-12 | |
| 2024-12-31 | $218.00K 10-Q · filed 2025-02-10 | |
| 2024-09-30 | $217.00K 10-K · filed 2025-11-25 | |
| 2024-06-30 | $217.00K 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $217.00K 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $200.00K 10-Q · filed 2024-02-06 | |
| 2023-09-30 | $200.00K 10-K · filed 2024-11-26 | |
| 2023-06-30 | $199.00K 10-Q · filed 2023-08-07 | |
| 2023-03-31 | $199.00K 10-Q · filed 2023-05-02 | |
| 2022-12-31 | $199.00K 10-Q · filed 2023-02-06 | |
| 2022-09-30 | $198.00K 10-K · filed 2023-11-29 | |
| 2022-06-30 | $198.00K 10-Q · filed 2022-08-04 | |
| 2022-03-31 | $198.00K 10-Q · filed 2022-05-10 | |
| 2021-12-31 | $197.00K 10-Q · filed 2022-02-02 | |
| 2021-09-30 | $197.00K 10-K · filed 2022-11-28 | |
| 2021-06-30 | $197.00K 10-Q · filed 2021-08-05 | |
| 2021-03-31 | $196.00K 10-Q · filed 2021-05-04 | |
| 2020-12-31 | $195.00K 10-Q · filed 2021-02-04 | |
| 2020-09-30 | $195.00K 10-K · filed 2021-11-22 | $194.75K 10-K · filed 2020-11-23 |
| 2020-06-30 | $194.62K 10-Q · filed 2020-08-05 | |
| 2020-03-31 | $194.12K 10-Q · filed 2020-05-07 | |
| 2019-12-31 | $193.48K 10-Q · filed 2020-02-05 | |
| 2019-09-30 | $187.88K 10-K · filed 2020-11-23 | |
| 2019-06-30 | $187.58K 10-Q · filed 2019-08-05 | |
| 2019-03-31 | $187.03K 10-Q · filed 2019-05-08 | |
| 2018-12-31 | $184.96K 10-Q · filed 2019-02-07 | |
| 2018-09-30 | $180.88K 10-K · filed 2019-11-25 | |
| 2018-06-30 | $180.22K 10-Q · filed 2018-08-07 | |
| 2018-03-31 | $179.94K 10-Q · filed 2018-05-08 | |
| 2017-12-31 | $167.29K 10-Q · filed 2018-02-09 | |
| 2017-09-30 | $167.16K 10-K · filed 2018-12-11 | |
| 2017-06-30 | $167.14K 10-Q · filed 2017-08-03 | |
| 2017-03-31 | $167.14K 10-Q · filed 2017-05-03 | |
| 2016-12-31 | $166.78K 10-Q · filed 2017-02-06 | |
| 2016-09-30 | $162.12K 10-K · filed 2017-12-12 | |
| 2016-06-30 | $152.80K 10-Q · filed 2016-08-09 | |
| 2016-03-31 | $152.33K 10-Q · filed 2016-05-10 | |
| 2015-12-31 | $152.00K 10-Q · filed 2016-02-09 | |
| 2015-09-30 | $151.91K 10-K · filed 2016-12-14 | |
| 2015-06-30 | $151.87K 10-Q · filed 2015-08-04 | |
| 2015-03-31 | $151.81K 10-Q · filed 2015-05-11 | |
| 2014-12-31 | $147.09K 10-Q · filed 2015-02-09 | |
| 2014-09-30 | $147.03K 10-K · filed 2015-12-14 | |
| 2014-06-30 | $145.28K 10-Q · filed 2014-08-12 | |
| 2014-03-31 | $144.24K 10-Q · filed 2014-05-06 | |
| 2013-12-31 | $131.37K 10-Q · filed 2014-02-04 | |
| 2013-09-30 | $124.86K 10-K · filed 2014-11-25 | |
| 2013-06-30 | $123.67K 10-Q · filed 2013-08-07 | |
| 2013-03-31 | $109.40K 10-Q · filed 2013-05-09 | |
| 2012-12-31 | $110.42K 10-Q · filed 2013-02-13 | |
| 2012-09-30 | $108.35K 10-K · filed 2013-12-18 | |
| 2012-06-30 | $106.09K 10-Q · filed 2012-08-13 | |
| 2012-03-31 | $105.58K 10-Q · filed 2012-05-08 | |
| 2011-12-31 | $105.31K 10-Q · filed 2012-02-09 | |
| 2011-09-30 | $86.42K 10-K · filed 2012-12-28 | |
| 2011-06-30 | $71.85K 10-Q · filed 2011-08-08 | |
| 2010-09-30 | $71.73K 10-K · filed 2011-12-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 |